Expert Interview
An in depth discussion of the clinical landscape for Macular Edema, with a close look at the phase 3 results of Kodiak Sciences tarcocimab and its potential in this space.
Ticker(s): KOD, REGNInstitution: University of Minnesota
- Vitreoreitnal surgeon
- Associate Professor of Ophthalmology at University of Minnesota
- Research Interest and Peer reviewed publications in imaging technology for vitreoretinal care and Macular degeneration.
- Present member of American Society of Retinal Specialists and Association for Research in Vision and Ophthalmology
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
